Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1980 1
1983 1
1984 1
1986 3
1988 6
1989 6
1990 7
1991 9
1992 5
1993 8
1994 15
1995 7
1996 18
1997 20
1998 17
1999 25
2000 25
2001 30
2002 41
2003 43
2004 82
2005 97
2006 113
2007 124
2008 170
2009 189
2010 212
2011 276
2012 315
2013 368
2014 377
2015 434
2016 464
2017 514
2018 589
2019 670
2020 835
2021 1034
2022 1133
2023 1139
2024 1135
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,388 results

Results by year

Filters applied: . Clear all
Page 1
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. Among authors: zheng mh. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Free article. Review.
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. Among authors: zheng m. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Free article. Clinical Trial.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: zheng m. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
1,2,3-Triazole hybrids with anti-HIV-1 activity.
Feng LS, Zheng MJ, Zhao F, Liu D. Feng LS, et al. Among authors: zheng mj. Arch Pharm (Weinheim). 2021 Jan;354(1):e2000163. doi: 10.1002/ardp.202000163. Epub 2020 Sep 22. Arch Pharm (Weinheim). 2021. PMID: 32960467 Review.
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial.
Lu J, Xing J, Zang L, Zhang C, Xu L, Zhang G, He Z, Sun Y, Feng Y, Du X, Hu S, Chi P, Huang Y, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Y, Zhang Z, Zheng M, Su X, Xiao Y; RELARC study group. Lu J, et al. Among authors: zheng m. J Clin Oncol. 2024 Nov 20;42(33):3957-3966. doi: 10.1200/JCO.24.00393. Epub 2024 Aug 27. J Clin Oncol. 2024. PMID: 39190853 Clinical Trial.
Natural killer cells in liver diseases.
Zheng M, Sun H, Tian Z. Zheng M, et al. Front Med. 2018 Jun;12(3):269-279. doi: 10.1007/s11684-018-0621-4. Epub 2018 Apr 19. Front Med. 2018. PMID: 29675689 Review.
9,388 results